The interaction of perfluoroalkyl acids and a family history of diabetes on arthritis: analyses of 2011–2018 NHANES

Shuting Yang,Xuqi Li,Zhengdong Jiang
DOI: https://doi.org/10.1186/s12889-024-17879-2
IF: 4.5
2024-02-14
BMC Public Health
Abstract:Whether a family history of diabetes (FHD) and exposure to perfluoroalkyl acids (PFAAs) are correlated with an increased risk of developing arthritis remains unclear. This cross-sectional study was conducted to explore the correlations between FHD or exposure to PFAAs and arthritis as well as their interaction using the National Health and Nutrition Examination Survey (NHANES). In total, 6,194 participants aged ≥ 20 years from the 2011–2018 NHANES were enrolled. PFAAs are a cluster of synthetic chemicals, including perfluorononanoic acid (PFNA), perfluorooctanoic acid (PFOA), perfluorooctane sulfonic acid (PFOS), perfluorodecanoic acid (PFDA) and perfluorohexane sulfonic acid (PFHxS). FHD was evaluated using self-reported questionnaires. Arthritis was classified into three types, rheumatoid arthritis (RA), osteoarthritis (OA), and others, which were diagnosed using questionnaires. Generalized linear models (GLMs) were used to test the correlation between FHD and arthritis. To examine the joint effects of PFAAs and FHD on arthritis, interaction terms were applied in the GLM. Arthritis incidence was 26.7% among all participants. FHD was associated with both RA [OR = 1.70 (95% CI: 1.15–2.50)] and other types of arthritis [OR = 1.62 (95% CI: 1.21–2.16)]. However, the relationship between FHD and OA was not significant after adjustment ( P = 0.18). Interaction outcomes indicated that higher PFDA levels increased the association between FHD and arthritis. FHD is associated with an increased incidence of arthritis, which may be increased by PFDA. Given the heavy burden of arthritis, preventive measures for arthritis and reduction of PFAAs exposure for patients with FHD are required.
public, environmental & occupational health
What problem does this paper attempt to address?
The problem that this paper attempts to solve is to explore whether family history of diabetes (FHD) and perfluoroalkyl acids (PFAAs) exposure are related to an increased risk of arthritis, and further study the impact of the interaction between FHD and PFAAs on arthritis. Specifically, the research aims to: 1. **Evaluate the relationship between FHD and arthritis**: By analyzing the data from the National Health and Nutrition Examination Survey (NHANES), study whether FHD is related to an increased incidence of arthritis. 2. **Evaluate the relationship between PFAAs and arthritis**: Study whether PFAAs exposure is related to an increased risk of arthritis. 3. **Explore the interaction between FHD and PFAAs**: Study how the interaction between FHD and PFAAs affects the risk of arthritis, especially whether PFAAs exacerbate the adverse effects of FHD on arthritis. ### Main findings - **Relationship between FHD and arthritis**: The study found that FHD is significantly associated with an increased incidence of arthritis, especially with an increased incidence of rheumatoid arthritis (RA) and other types of arthritis (non - RA or OA). However, after adjustment, the relationship between FHD and osteoarthritis (OA) is not significant. - **Relationship between PFAAs and arthritis**: The study found that the PFDA level in PFAAs is significantly associated with an increased incidence of arthritis, especially with an increased incidence of RA and other types of arthritis. - **Interaction between FHD and PFAAs**: The study found that an increase in the PFDA level will exacerbate the adverse effects of FHD on arthritis, that is, PFDA may promote an increased incidence of arthritis in FHD patients. ### Conclusion This study reveals for the first time the significant association between FHD and arthritis, and finds that PFDA in PFAAs may exacerbate this association. Therefore, reducing PFAAs exposure is of great significance for preventing arthritis in FHD patients.